Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine and Divalproex in Bipolar I Disorder Mixed Episode
NCT00402324Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar I disorder comparing Olanzapine + Divalproex with Placebo + Divalproex (2 arms). Primary endpoints: Young Mania Rating Scale at 6 weeks and Hamilton Depression Rating Scale-21 at 6 weeks. Started Dec 2006; status: completed.
02
Drugs
olanzapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00402324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402324.